Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
allergan
biotech
clinical trials
life sciences
national blog main
boston blog main
crispr
deals
editas medicine
europe blog main
fda
national
national top stories
new york blog main
san francisco blog main
akouos
alnylam pharmaceuticals
alzheimer's disease
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
biohaven
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
cgpr
covid-19
cynthia collins
deerfield management
detroit blog main
detroit top stories
What
medicines
3
×
treatment
abbvie
acquisitions
adults
allergan
alliance
announced
approved
bio
biotech
ceo
class
collabs
covid
daniel
deal
editas
editing
exits
experimental
fda
gene
genetic
gilead
gilead’s
help
introduce
ipo
migraine
monday
month
new
nod
o’day
pact
partnership
pill
plans
pruning
Language
unset
Current search:
abbvie
×
medicines
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines